{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:31:08Z","timestamp":1792794668035,"version":"4.5.0"},"reference-count":146,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jaut.2019.102339","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T17:51:27Z","timestamp":1570816287000},"page":"102339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"special_numbering":"C","title":["The immunobiology of autoimmune encephalitides"],"prefix":"10.1016","volume":"104","author":[{"given":"Harry","family":"Alexopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinos C.","family":"Dalakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jaut.2019.102339_bib1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1152\/physrev.00010.2016","article-title":"Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system","volume":"97","author":"Dalmau","year":"2017","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.jaut.2019.102339_bib2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jaut.2019.102339_bib3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/nyas.12553","article-title":"Autoimmune encephalopathies","volume":"1338","author":"Leypoldt","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jaut.2019.102339_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fpsyt.2017.00013","article-title":"Lennox BR. Synaptic and neuronal autoantibody-associated psychiatric syndromes: controversies and hypotheses","volume":"8","author":"Al-Diwani","year":"2017","journal-title":"Front. Psychiatry"},{"issue":"9","key":"10.1016\/j.jaut.2019.102339_bib5","doi-asserted-by":"crossref","first-page":"102348","DOI":"10.1016\/j.autrev.2019.102348","article-title":"Autoimmunity in psychotic disorders. Where we stand, challenges and opportunities","volume":"18","author":"Mane-Damas","year":"2019","journal-title":"Autoimmun. Rev."},{"issue":"6","key":"10.1016\/j.jaut.2019.102339_bib6","first-page":"1271","article-title":"Encephalitis and postinfectious encephalitis","volume":"18","author":"Greenlee","year":"2012","journal-title":"Continuum"},{"issue":"3","key":"10.1016\/j.jaut.2019.102339_bib7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/WCO.0000000000000087","article-title":"Autoimmune encephalitis as differential diagnosis of infectious encephalitis","volume":"27","author":"Armangue","year":"2014","journal-title":"Curr. Opin. Neurol."},{"issue":"7\u20138","key":"10.1016\/j.jaut.2019.102339_bib8","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.neurol.2019.07.004","article-title":"The role of infections in autoimmune encephalitides","volume":"175","author":"Joubert","year":"2019","journal-title":"Rev. Neurol."},{"issue":"1","key":"10.1016\/j.jaut.2019.102339_bib9","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1038\/s41598-019-41849-z","article-title":"In vitro neuronal network activity as a new functional diagnostic system to detect effects of Cerebrospinal fluid from autoimmune encephalitis patients","volume":"9","author":"Koch","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2019.102339_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/B978-0-444-63432-0.00007-4","article-title":"Neuropathology of autoimmune encephalitides","volume":"133","author":"Bauer","year":"2016","journal-title":"Handb. Clin. Neurol."},{"issue":"11","key":"10.1016\/j.jaut.2019.102339_bib11","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.it.2015.09.008","article-title":"Antibodies as mediators of brain pathology","volume":"36","author":"Brimberg","year":"2015","journal-title":"Trends Immunol."},{"issue":"12","key":"10.1016\/j.jaut.2019.102339_bib12","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol."},{"issue":"17","key":"10.1016\/j.jaut.2019.102339_bib13","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1212\/WNL.0b013e3182a9585f","article-title":"Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients","volume":"81","author":"Hoftberger","year":"2013","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jaut.2019.102339_bib14","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.21589","article-title":"AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location","volume":"65","author":"Lai","year":"2009","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.jaut.2019.102339_bib15","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archneur.65.7.913","article-title":"Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis","volume":"65","author":"Waters","year":"2008","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.jaut.2019.102339_bib16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jamaneurol.2013.592","article-title":"Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping","volume":"70","author":"Klein","year":"2013","journal-title":"JAMA neurology"},{"issue":"11","key":"10.1016\/j.jaut.2019.102339_bib17","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1586\/1744666X.2013.845527","article-title":"Immunology of stiff person syndrome and other GAD-associated neurological disorders","volume":"9","author":"Alexopoulos","year":"2013","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"7","key":"10.1016\/j.jaut.2019.102339_bib18","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1212\/01.wnl.0000299189.43164.96","article-title":"Limbic encephalitis: an expanding concept","volume":"70","author":"Graus","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.102339_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-1-4939-7321-7_4","article-title":"Detection of NMDARs antibodies in encephalitis","volume":"1677","author":"Gastaldi","year":"2017","journal-title":"Methods Mol. Biol."},{"issue":"5","key":"10.1016\/j.jaut.2019.102339_bib20","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.25460","article-title":"N-methyl-D-aspartate receptor dysfunction by unmutated human antibodies against the NR1 subunit","volume":"85","author":"Wenke","year":"2019","journal-title":"Ann. Neurol."},{"issue":"Pt 10","key":"10.1016\/j.jaut.2019.102339_bib21","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1093\/brain\/aww208","article-title":"Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis","volume":"139","author":"Kreye","year":"2016","journal-title":"Brain : J. Neurol."},{"issue":"2","key":"10.1016\/j.jaut.2019.102339_bib22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.24200","article-title":"Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms","volume":"76","author":"Irani","year":"2014","journal-title":"Ann. Neurol."},{"issue":"13","key":"10.1016\/j.jaut.2019.102339_bib23","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1016\/j.celrep.2018.05.096","article-title":"NMDA receptor autoantibodies in autoimmune encephalitis cause a subunit-specific nanoscale redistribution of NMDA receptors","volume":"23","author":"Ladepeche","year":"2018","journal-title":"Cell Rep."},{"issue":"Pt 5","key":"10.1016\/j.jaut.2019.102339_bib24","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/brain\/aws092","article-title":"Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis","volume":"135","author":"Mikasova","year":"2012","journal-title":"Brain : J. Neurol."},{"key":"10.1016\/j.jaut.2019.102339_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.conb.2017.07.012","article-title":"Neurobiology of autoimmune encephalitis","volume":"48","author":"Fukata","year":"2018","journal-title":"Curr. Opin. Neurobiol."},{"issue":"10","key":"10.1016\/j.jaut.2019.102339_bib26","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1007\/s00415-018-8970-0","article-title":"Malignant tumors in autoimmune encephalitis with anti-NMDA receptor antibodies","volume":"265","author":"Bost","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.jaut.2019.102339_bib27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/B978-0-444-63432-0.00005-0","article-title":"Cellular, synaptic, and circuit effects of antibodies in autoimmune CNS synaptopathies","volume":"133","author":"Jain","year":"2016","journal-title":"Handb. Clin. Neurol."},{"issue":"9","key":"10.1016\/j.jaut.2019.102339_bib28","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.jaut.2019.102339_bib29","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/WCO.0000000000000444","article-title":"Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies)","volume":"30","author":"Bastiaansen","year":"2017","journal-title":"Curr. Opin. Neurol."},{"issue":"8","key":"10.1016\/j.jaut.2019.102339_bib30","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1474-4422(11)70096-5","article-title":"Autoantibodies associated with diseases of the CNS: new developments and future challenges","volume":"10","author":"Vincent","year":"2011","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.jaut.2019.102339_bib31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/ene.13180","article-title":"Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcome","volume":"24","author":"Bien","year":"2017","journal-title":"Eur. J. Neurol."},{"issue":"9","key":"10.1016\/j.jaut.2019.102339_bib32","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/jamaneurol.2016.1585","article-title":"Characterization of a subtype of autoimmune encephalitis with anti-contactin-associated protein-like 2 antibodies in the cerebrospinal fluid, prominent limbic symptoms, and seizures","volume":"73","author":"Joubert","year":"2016","journal-title":"JAMA neurology"},{"issue":"2","key":"10.1016\/j.jaut.2019.102339_bib33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.23577","article-title":"Morvan syndrome: clinical and serological observations in 29 cases","volume":"72","author":"Irani","year":"2012","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.jaut.2019.102339_bib34","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/jnnp-2017-315720","article-title":"LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes","volume":"89","author":"Binks","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"8","key":"10.1016\/j.jaut.2019.102339_bib35","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/jamaneurol.2015.0749","article-title":"Paraneoplastic neurological syndromes and glutamic acid decarboxylase antibodies","volume":"72","author":"Arino","year":"2015","journal-title":"JAMA neurology"},{"issue":"11","key":"10.1016\/j.jaut.2019.102339_bib36","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1365-2362.2010.02340.x","article-title":"A critical update on the immunopathogenesis of Stiff Person Syndrome","volume":"40","author":"Alexopoulos","year":"2010","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.jaut.2019.102339_bib37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.expneurol.2013.02.010","article-title":"Progress and stiff challenges in understanding the role of GAD-antibodies in stiff-person syndrome","volume":"247","author":"Dalakas","year":"2013","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.jaut.2019.102339_bib38","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ana.410440209","article-title":"Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome","volume":"44","author":"Dinkel","year":"1998","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.jaut.2019.102339_bib39","doi-asserted-by":"crossref","first-page":"7755","DOI":"10.4049\/jimmunol.175.11.7755","article-title":"Analysis of GAD65 autoantibodies in Stiff-Person syndrome patients","volume":"175","author":"Raju","year":"2005","journal-title":"J. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.jaut.2019.102339_bib40","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jneuroim.2010.07.019","article-title":"Qualitative and quantitative evidence of anti-glutamic acid decarboxylase-specific intrathecal antibody synthesis in patients with stiff person syndrome","volume":"229","author":"Jarius","year":"2010","journal-title":"J. Neuroimmunol."},{"issue":"6","key":"10.1016\/j.jaut.2019.102339_bib41","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1001\/archneur.61.6.902","article-title":"Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity","volume":"61","author":"Rakocevic","year":"2004","journal-title":"Arch. Neurol."},{"issue":"11","key":"10.1016\/j.jaut.2019.102339_bib42","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1212\/01.WNL.0000127446.61806.2F","article-title":"Stiff person syndrome does not always occur with maternal passive transfer of GAD65 antibodies","volume":"62","author":"Nemni","year":"2004","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.jaut.2019.102339_bib43","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1212\/WNL.55.10.1531","article-title":"The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome","volume":"55","author":"Dalakas","year":"2000","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jaut.2019.102339_bib44","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11940-009-0013-9","article-title":"Stiff person syndrome: advances in pathogenesis and therapeutic interventions","volume":"11","author":"Dalakas","year":"2009","journal-title":"Curr. Treat. Options Neurol."},{"issue":"7","key":"10.1016\/j.jaut.2019.102339_bib45","doi-asserted-by":"crossref","first-page":"522","DOI":"10.7326\/0003-4819-131-7-199910050-00008","article-title":"The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of gamma-aminobutyric acid","volume":"131","author":"Levy","year":"1999","journal-title":"Ann. Intern. Med."},{"issue":"Pt 10","key":"10.1016\/j.jaut.2019.102339_bib46","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1093\/brain\/awn221","article-title":"Stiff, twitchy or wobbly: are GAD antibodies pathogenic?","volume":"131","author":"Vincent","year":"2008","journal-title":"Brain"},{"issue":"17","key":"10.1016\/j.jaut.2019.102339_bib47","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1212\/WNL.0b013e3182a9585f","article-title":"Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients","volume":"81","author":"Hoftberger","year":"2013","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.jaut.2019.102339_bib48","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1212\/WNL.0b013e3182a35271","article-title":"GABAB receptor autoantibody frequency in service serologic evaluation","volume":"81","author":"Jeffery","year":"2013","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jaut.2019.102339_bib49","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen","volume":"9","author":"Lancaster","year":"2010","journal-title":"Lancet Neurol."},{"issue":"1\u20132","key":"10.1016\/j.jaut.2019.102339_bib50","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jneuroim.2013.04.004","article-title":"GABA-B-receptor antibodies in paraneoplastic brainstem encephalitis","volume":"259","author":"Mundiyanapurath","year":"2013","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.jaut.2019.102339_bib51","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1212\/NXI.0000000000000039","article-title":"Autoimmune encephalitis with GABAB antibodies, thymoma, and GABAB receptor thymic expression","volume":"1","author":"Alexopoulos","year":"2014","journal-title":"Neurol. (R) Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.jaut.2019.102339_bib52","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/B978-0-444-63432-0.00017-7","article-title":"Autoimmune movement disorders","volume":"133","author":"McKeon","year":"2016","journal-title":"Handb. Clin. Neurol."},{"issue":"3","key":"10.1016\/j.jaut.2019.102339_bib53","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/WCO.0000000000000450","article-title":"Redefining progressive encephalomyelitis with rigidity and myoclonus after the discovery of antibodies to glycine receptors","volume":"30","author":"Crisp","year":"2017","journal-title":"Curr. Opin. Neurol."},{"issue":"8","key":"10.1016\/j.jaut.2019.102339_bib54","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/01.wnl.0000343001.36493.ae","article-title":"Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders","volume":"72","author":"Magana","year":"2009","journal-title":"Neurology"},{"issue":"Pt 8","key":"10.1016\/j.jaut.2019.102339_bib55","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/brain\/awu142","article-title":"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes","volume":"137","author":"Carvajal-Gonzalez","year":"2014","journal-title":"Brain : J. Neurol."},{"issue":"4","key":"10.1016\/j.jaut.2019.102339_bib56","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1055\/s-0034-1390394","article-title":"Neuronal surface antibody-mediated autoimmune encephalitis","volume":"34","author":"Linnoila","year":"2014","journal-title":"Semin. Neurol."},{"issue":"8","key":"10.1016\/j.jaut.2019.102339_bib57","first-page":"512","article-title":"The pathophysiology of paraneoplastic neurological syndromes","volume":"149","author":"Liblau","year":"1998","journal-title":"Ann. Med. Interne"},{"issue":"3","key":"10.1016\/j.jaut.2019.102339_bib58","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1055\/s-0038-1660821","article-title":"An overview of autoimmune and paraneoplastic encephalitides","volume":"38","author":"Bradshaw","year":"2018","journal-title":"Semin. Neurol."},{"issue":"2","key":"10.1016\/j.jaut.2019.102339_bib59","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1353\/pbm.1995.0043","article-title":"Anti-Hu autoantibody associated sensory neuropathy\/encephalomyelitis: a model of paraneoplastic syndrome","volume":"38","author":"Posner","year":"1995","journal-title":"Perspect. Biol. Med."},{"issue":"1","key":"10.1016\/j.jaut.2019.102339_bib60","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/ana.410380117","article-title":"Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites","volume":"38","author":"Manley","year":"1995","journal-title":"Ann. Neurol."},{"issue":"10 Pt B","key":"10.1016\/j.jaut.2019.102339_bib61","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1016\/j.bbamem.2015.04.003","article-title":"Autoimmune channelopathies in paraneoplastic neurological syndromes","volume":"1848","author":"Joubert","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jaut.2019.102339_bib62","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3389\/fimmu.2017.00442","article-title":"Hello from the other side: how autoantibodies circumvent the blood-brain barrier in autoimmune encephalitis","volume":"8","author":"Platt","year":"2017","journal-title":"Front. Immunol."},{"issue":"Pt 5","key":"10.1016\/j.jaut.2019.102339_bib63","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/brain\/aws082","article-title":"Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis","volume":"135","author":"Bien","year":"2012","journal-title":"Brain : J. Neurol."},{"issue":"1","key":"10.1016\/j.jaut.2019.102339_bib64","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12974-016-0737-x","article-title":"Inositol 1,4,5-trisphosphate receptor type 1 autoantibodies in paraneoplastic and non-paraneoplastic peripheral neuropathy","volume":"13","author":"Jarius","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jaut.2019.102339_bib65","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12974-014-0160-0","article-title":"Neuronal uptake of anti-Hu antibody, but not anti-Ri antibody, leads to cell death in brain slice cultures","volume":"11","author":"Greenlee","year":"2014","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.jaut.2019.102339_bib66","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/brain\/awx189","article-title":"Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology","volume":"141","author":"Balint","year":"2018","journal-title":"Brain : J. Neurol."},{"key":"10.1016\/j.jaut.2019.102339_bib67","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.brainres.2018.09.009","article-title":"Pathogenic role of autoantibodies against inhibitory synapses","volume":"1701","author":"Pruss","year":"2018","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.jaut.2019.102339_bib68","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/01.wco.0000180660.57801.3f","article-title":"Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis","volume":"18","author":"Vincent","year":"2005","journal-title":"Curr. Opin. Neurol."},{"issue":"6","key":"10.1016\/j.jaut.2019.102339_bib69","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41582-019-0174-4","article-title":"Immunoneuropsychiatry - novel perspectives on brain disorders","volume":"15","author":"Pape","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jaut.2019.102339_bib70","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fpsyt.2017.00025","article-title":"Red flags: clinical signs for identifying autoimmune encephalitis in psychiatric patients","volume":"8","author":"Herken","year":"2017","journal-title":"Front. Psychiatry"},{"issue":"5","key":"10.1016\/j.jaut.2019.102339_bib71","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/pcn.12821","article-title":"Recognizing psychiatric presentations of anti-NMDA receptor encephalitis in children and adolescents: a synthesis of published reports","volume":"73","author":"Gurrera","year":"2019","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.jaut.2019.102339_bib72","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.psym.2015.01.003","article-title":"Psychiatric autoimmunity: N-Methyl-D-Aspartate receptor IgG and beyond","volume":"56","author":"Kruse","year":"2015","journal-title":"Psychosomatics"},{"issue":"4","key":"10.1016\/j.jaut.2019.102339_bib73","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.biopsych.2013.07.040","article-title":"Do neuronal autoantibodies cause psychosis? A neuroimmunological perspective","volume":"75","author":"Coutinho","year":"2014","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.jaut.2019.102339_bib74","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/imm.12795","article-title":"Lennox BR. Psychosis: an autoimmune disease?","volume":"152","author":"Al-Diwani","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2019.102339_bib75","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3389\/fpsyt.2019.00169","article-title":"Editorial: recent advances in psychiatry from psycho-neuro-immunology research: autoimmune encephalitis, autoimmune encephalopathy, and mild encephalitis","volume":"10","author":"Bechter","year":"2019","journal-title":"Front. Psychiatry"},{"issue":"4","key":"10.1016\/j.jaut.2019.102339_bib76","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.neurol.2017.11.004","article-title":"Autoimmune encephalitis and psychiatric disorders","volume":"174","author":"Honnorat","year":"2018","journal-title":"Rev. Neurol."},{"issue":"12","key":"10.1016\/j.jaut.2019.102339_bib77","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1038\/mp.2016.125","article-title":"All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin class","volume":"22","author":"Castillo-Gomez","year":"2017","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.jaut.2019.102339_bib78","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1038\/s41467-017-01700-3","article-title":"Dynamic disorganization of synaptic NMDA receptors triggered by autoantibodies from psychotic patients","volume":"8","author":"Jezequel","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2019.102339_bib79","series-title":"Autoantibodies and psychosis","author":"Kelleher","year":"2019"},{"issue":"2","key":"10.1016\/j.jaut.2019.102339_bib80","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000499714","article-title":"Clinically relevant anti-neuronal cell surface antibodies in schizophrenia spectrum disorders","volume":"78","author":"Colijn","year":"2019","journal-title":"Neuropsychobiology"},{"issue":"16","key":"10.1016\/j.jaut.2019.102339_bib81","doi-asserted-by":"crossref","first-page":"e1386","DOI":"10.1212\/WNL.0000000000005329","article-title":"Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor","volume":"90","author":"Hara","year":"2018","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.jaut.2019.102339_bib82","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1212\/01.WNL.0000163984.71993.FE","article-title":"A neuropsychological assessment of phobias in patients with stiff person syndrome","volume":"64","author":"Ameli","year":"2005","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.jaut.2019.102339_bib83","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1176\/appi.ajp.2011.11030516","article-title":"Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study","volume":"168","author":"Benros","year":"2011","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.jaut.2019.102339_bib84","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/00365520600863472","article-title":"Coeliac disease and risk of schizophrenia and other psychosis: a general population cohort study","volume":"42","author":"Ludvigsson","year":"2007","journal-title":"Scand. J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.jaut.2019.102339_bib85","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/mp.2008.5","article-title":"Are some cases of psychosis caused by microbial agents? A review of the evidence","volume":"13","author":"Yolken","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jaut.2019.102339_bib86","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature08186","article-title":"Common variants conferring risk of schizophrenia","volume":"460","author":"Stefansson","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2019.102339_bib87","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbi.2014.10.001","article-title":"Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment","volume":"43","author":"Isgren","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jaut.2019.102339_bib88","doi-asserted-by":"crossref","first-page":"d5652","DOI":"10.1136\/bmj.d5652","article-title":"Hospital admission for schizophrenia and bipolar disorder","volume":"343","author":"Miller","year":"2011","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jaut.2019.102339_bib89","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.biopsych.2013.01.007","article-title":"Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies","volume":"74","author":"Modabbernia","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.jaut.2019.102339_bib90","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1503\/jpn.140183","article-title":"Monocyte and microglial activation in patients with mood-stabilized bipolar disorder","volume":"40","author":"Jakobsson","year":"2015","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.jaut.2019.102339_bib91","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1742-2094-10-142","article-title":"Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence","volume":"10","author":"Najjar","year":"2013","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.jaut.2019.102339_bib92","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.psychres.2014.03.045","article-title":"Blood-cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment","volume":"217","author":"Zetterberg","year":"2014","journal-title":"Psychiatry Res."},{"issue":"8","key":"10.1016\/j.jaut.2019.102339_bib93","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.bbi.2009.04.008","article-title":"Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder","volume":"23","author":"Brietzke","year":"2009","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.jaut.2019.102339_bib94","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jad.2008.12.001","article-title":"Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder","volume":"116","author":"Brietzke","year":"2009","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.jaut.2019.102339_bib95","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.autrev.2014.09.001","article-title":"The importance of cytokines and autoantibodies in depression","volume":"14","author":"Postal","year":"2015","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.jaut.2019.102339_bib96","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"issue":"9","key":"10.1016\/j.jaut.2019.102339_bib97","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.jaut.2019.102339_bib98","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1176\/appi.ajp.158.8.1252","article-title":"Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings","volume":"158","author":"Musselman","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.jaut.2019.102339_bib99","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.neubiorev.2011.12.005","article-title":"Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression","volume":"36","author":"Leonard","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.jaut.2019.102339_bib100","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","article-title":"Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors","volume":"35","author":"Berk","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.jaut.2019.102339_bib101","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pnpbp.2011.09.006","article-title":"Activation of cell-mediated immunity in depression: association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression","volume":"36","author":"Maes","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatr."},{"issue":"5","key":"10.1016\/j.jaut.2019.102339_bib102","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.jaut.2019.102339_bib103","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jad.2011.08.003","article-title":"Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression","volume":"139","author":"Liu","year":"2012","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.jaut.2019.102339_bib104","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S2215-0366(19)30038-0","article-title":"A transdiagnostic pattern of psychiatric symptoms in autoimmune encephalitis","volume":"6","author":"Finke","year":"2019","journal-title":"The lancet Psychiatr."},{"key":"10.1016\/j.jaut.2019.102339_bib105","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3389\/fpsyt.2019.00226","article-title":"Systemic lupus erythematosus with isolated psychiatric symptoms and antinuclear antibody detection in the cerebrospinal fluid","volume":"10","author":"Lungen","year":"2019","journal-title":"Front. Psychiatry"},{"issue":"Pt 1","key":"10.1016\/j.jaut.2019.102339_bib106","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/brain\/awu310","article-title":"Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice","volume":"138","author":"Planaguma","year":"2015","journal-title":"Brain : J. Neurol."},{"key":"10.1016\/j.jaut.2019.102339_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(19)30244-3","article-title":"An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models","author":"Dalmau","year":"2019","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.jaut.2019.102339_bib108","first-page":"3144","article-title":"LGI1 antibodies alter Kv1.1 and AMPA receptors changing synaptic excitability, plasticity and memory","volume":"141","author":"Petit-Pedrol","year":"2018","journal-title":"Brain : J. Neurol."},{"issue":"1","key":"10.1016\/j.jaut.2019.102339_bib109","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neuron.2018.07.048","article-title":"Human autoantibodies against the AMPA receptor subunit GluA2 induce receptor reorganization and memory dysfunction","volume":"100","author":"Haselmann","year":"2018","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.jaut.2019.102339_bib110","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1093\/brain\/awz119","article-title":"Behaviour and neuropathology in mice injected with human contactin-associated protein 2 antibodies","volume":"142","author":"Giannoccaro","year":"2019","journal-title":"Brain : J. Neurol."},{"issue":"2","key":"10.1016\/j.jaut.2019.102339_bib111","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ana.24083","article-title":"Herpes simplex virus encephalitis is a trigger of brain autoimmunity","volume":"75","author":"Armangue","year":"2014","journal-title":"Ann. Neurol."},{"issue":"10045","key":"10.1016\/j.jaut.2019.102339_bib112","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barre syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet (Lon., Engl.)"},{"key":"10.1016\/j.jaut.2019.102339_bib113","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12916-016-0601-y","article-title":"Zika virus and neurologic autoimmunity: the putative role of gangliosides","volume":"14","author":"Anaya","year":"2016","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.jaut.2019.102339_bib114","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2217\/fnl.16.4","article-title":"CNS autoimmune disease after Streptococcus pyogenes infections: animal models, cellular mechanisms and genetic factors","volume":"11","author":"Cutforth","year":"2016","journal-title":"Future Neurol."},{"key":"10.1016\/j.jaut.2019.102339_bib115","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.msard.2017.05.009","article-title":"Epstein-Barr virus and multiple sclerosis: updating Pender's hypothesis","volume":"16","author":"Laurence","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"9","key":"10.1016\/j.jaut.2019.102339_bib116","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1474-4422(18)30244-8","article-title":"Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis","volume":"17","author":"Armangue","year":"2018","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.jaut.2019.102339_bib117","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.1212\/NXI.0000000000000245","article-title":"CSF herpes virus and autoantibody profiles in the evaluation of encephalitis","volume":"3","author":"Linnoila","year":"2016","journal-title":"Neurol. (R) Neuroimmunol. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.jaut.2019.102339_bib118","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pediatrneurol.2015.03.013","article-title":"Virus and immune-mediated encephalitides: epidemiology, diagnosis, treatment, and prevention","volume":"53","author":"Bale","year":"2015","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.jaut.2019.102339_bib119","doi-asserted-by":"crossref","unstructured":"Bradshaw MJ, Venkatesan A. Herpes simplex virus-1 encephalitis in adults: pathophysiology, diagnosis, and management. Neurotherapeutics.13(3):493-508.","DOI":"10.1007\/s13311-016-0433-7"},{"issue":"1","key":"10.1016\/j.jaut.2019.102339_bib120","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ana.25131","article-title":"Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis","volume":"83","author":"Dubey","year":"2018","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.jaut.2019.102339_bib121","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1007\/s00415-011-5982-4","article-title":"Paraneoplastic anti-NMDAR encephalitis: long term follow-up reveals persistent serum antibodies","volume":"258","author":"Alexopoulos","year":"2011","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.jaut.2019.102339_bib122","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","article-title":"Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study","volume":"13","author":"Gresa-Arribas","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jaut.2019.102339_bib123","doi-asserted-by":"crossref","DOI":"10.1177\/1756286418768778","article-title":"Postherpes simplex encephalitis: a case series of viral-triggered autoimmunity, synaptic autoantibodies and response to therapy","volume":"11","author":"Alexopoulos","year":"2018","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"24","key":"10.1016\/j.jaut.2019.102339_bib124","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1212\/WNL.0000000000002218","article-title":"Herpes simplex virus 1 encephalitis associated with voltage-gated calcium channel autoimmunity","volume":"85","author":"Bradshaw","year":"2015","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jaut.2019.102339_bib125","doi-asserted-by":"crossref","first-page":"e458","DOI":"10.1212\/NXI.0000000000000458","article-title":"Anti-NMDA receptor encephalitis and nonencephalitic HSV-1 infection","volume":"5","author":"Salovin","year":"2018","journal-title":"Neurol.Neurol. (R) Neuroimmunol. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.jaut.2019.102339_bib126","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/mus.23869","article-title":"West nile virus infection and myasthenia gravis","volume":"49","author":"Leis","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaut.2019.102339_bib127","series-title":"West Nile Virus Infection Triggering Autoimmune Encephalitis: Pathophysiological and Therapeutic Implications","author":"Karagianni","year":"2019"},{"issue":"1","key":"10.1016\/j.jaut.2019.102339_bib128","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/1756285615614812","article-title":"Progressive encephalomyelitis with rigidity and myoclonus (PERM): brucellosis as a possible triggering factor and long-term follow-up therapy with rituximab","volume":"9","author":"Magira","year":"2016","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"6","key":"10.1016\/j.jaut.2019.102339_bib129","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/archneur.61.6.938","article-title":"Stiff-person syndrome following West Nile fever","volume":"61","author":"Hassin-Baer","year":"2004","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.jaut.2019.102339_bib130","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-0038-1660501","article-title":"Antibodies in autoimmune human neurological disease: pathogenesis and immunopathology","volume":"38","author":"Williams","year":"2018","journal-title":"Semin. Neurol."},{"issue":"4","key":"10.1016\/j.jaut.2019.102339_bib131","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/1759-7714.13009","article-title":"Paraneoplastic autoimmunity and small-cell lung cancer: neurological and serological accompaniments","volume":"10","author":"Zekeridou","year":"2019","journal-title":"Thorac. Can."},{"issue":"5","key":"10.1016\/j.jaut.2019.102339_bib132","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ana.24884","article-title":"Identity of the Purkinje cell cytoplasmic antibody type 2 autoantibody antigen is finally revealed","volume":"81","author":"Gonzalez-Billault","year":"2017","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.jaut.2019.102339_bib133","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1212\/NXI.0000000000000068","article-title":"Standardized test for anti-Tr\/DNER in patients with paraneoplastic cerebellar degeneration","volume":"2","author":"Probst","year":"2015","journal-title":"Neurol. (R) Neuroimmunol. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.jaut.2019.102339_bib134","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12974-016-0689-1","article-title":"Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome","volume":"13","author":"Sabater","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.jaut.2019.102339_bib135","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1212\/WNL.0000000000001721","article-title":"Paraneoplastic neurologic disorders in small cell lung carcinoma: a prospective study","volume":"85","author":"Gozzard","year":"2015","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jaut.2019.102339_bib136","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/brain\/awz094","article-title":"The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies","volume":"142","author":"van Coevorden-Hameete","year":"2019","journal-title":"Brain : J. Neurol."},{"issue":"3","key":"10.1016\/j.jaut.2019.102339_bib137","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.autrev.2013.10.016","article-title":"Molecular and cellular mechanisms underlying anti-neuronal antibody mediated disorders of the central nervous system","volume":"13","author":"van Coevorden-Hameete","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"9","key":"10.1016\/j.jaut.2019.102339_bib138","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.jaut.2019.102339_bib139","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41571-019-0194-4","article-title":"Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors","volume":"16","author":"Graus","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jaut.2019.102339_bib140","doi-asserted-by":"crossref","DOI":"10.1177\/1756286418799864","article-title":"Neurological complications of immune checkpoint inhibitors: what happens when you 'take the brakes off' the immune system","volume":"11","author":"Dalakas","year":"2018","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.jaut.2019.102339_bib141","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ejca.2017.09.026","article-title":"Immune checkpoint inhibitor-associated CNS autoimmune disorder (ICICAD) following nivolumab treatment: a new entity of drug-induced autoimmune encephalitis?","volume":"87","author":"Strik","year":"2017","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.jaut.2019.102339_bib142","first-page":"267","article-title":"Pembrolizumab-induced autoimmune encephalitis in a patient with advanced non-small cell lung cancer: a case report","volume":"10","author":"Niki","year":"2019","journal-title":"Mol.clin. oncol."},{"issue":"2","key":"10.1016\/j.jaut.2019.102339_bib143","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1159\/000477162","article-title":"PD-1 checkpoint inhibitor associated autoimmune encephalitis","volume":"10","author":"Schneider","year":"2017","journal-title":"Case rep. oncol."},{"key":"10.1016\/j.jaut.2019.102339_bib144","first-page":"2548528","article-title":"Nivolumab-induced autoimmune encephalitis in two patients with lung adenocarcinoma","volume":"2018","author":"Shah","year":"2018","journal-title":"Case rep. neurol. Med."},{"issue":"2","key":"10.1016\/j.jaut.2019.102339_bib145","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1395125","article-title":"Assessment of neuronal autoantibodies in patients with small cell lung cancer treated with chemotherapy with or without ipilimumab","volume":"7","author":"Hardy-Werbin","year":"2018","journal-title":"OncoImmunology"},{"key":"10.1016\/j.jaut.2019.102339_bib146","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.neuropharm.2017.04.046","article-title":"Autoantibody-mediated diseases of the CNS: structure, dysfunction and therapy","volume":"132","author":"Varley","year":"2018","journal-title":"Neuropharmacology"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841119306213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841119306213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:23:22Z","timestamp":1760257402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841119306213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":146,"alternative-id":["S0896841119306213"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2019.102339","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The immunobiology of autoimmune encephalitides","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2019.102339","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102339"}}